Cancer therapies that harness a patient’s own immune system to improve the body’s ability to fight off cancer have shown promising outcomes. One such immunotherapy is chimeric antigen receptor (CAR) T ...
Post-Hoc Analysis Using Computer Automated Grading Indicated that Reproxalap is Statistically Superior to Vehicle (p=0.020) in Reducing Dry-Eye Associated Ocular Redness, the Primary Endpoint of Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results